Literature DB >> 1879902

Serum levels of gentamicin at peak and trough in neonates and infants.

M Shahidullah1, M Q Talukder, A K Chowdhury, S Ali, A Rashid.   

Abstract

The peak and the trough levels of serum gentamicin were determined in 50 cases of neonates and infants by microbiological assay method. The peak levels in the neonates and the infants were 5.98 +/- 0.48 and 4.63 +/- 0.31 mcg/ml respectively. The trough levels in the corresponding group were 1.06 +/- 0.19 and 0.94 +/- 0.23 mcg/ml. The mean values of the peak and trough levels of the antibiotic were 5.57 and 1.02 mcg/ml respectively. It was observed that there was a significant lower peak concentration in the infants than in the neonates. A significantly higher peak concentration of gentamicin was observed in babies aged under 7 days than in those above 7 days. The route of administration (between I/M and I/V) did not seem to have any effect on the peak and trough levels of the antibiotics.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1879902     DOI: 10.1007/bf02751124

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  24 in total

1.  Gentamicin blood levels: a guide to nephrotoxicity.

Authors:  J G Dahlgren; E T Anderson; W L Hewitt
Journal:  Antimicrob Agents Chemother       Date:  1975-07       Impact factor: 5.191

2.  Intravenous injection of gentamicin and tobramycin without impairment of hearing.

Authors:  S M Dobbs; G E Mawer
Journal:  J Infect Dis       Date:  1976-08       Impact factor: 5.226

3.  Gentamicin serum concentrations: pharmacokinetic predictions.

Authors:  J H Hull; F A Sarubbi
Journal:  Ann Intern Med       Date:  1976-08       Impact factor: 25.391

4.  A simple method for determining gentamicin blood levels.

Authors:  A Mates; D Wolkoff
Journal:  Microbios       Date:  1983

5.  Gentamicin dosage in children: a randomized prospective comparison of body weight and body surface area as dose determinants.

Authors:  W E Evans; S Feldman; M Ossi; R H Taylor; S Chaudhary; E T Melton; L F Barker
Journal:  J Pediatr       Date:  1979-01       Impact factor: 4.406

6.  Pharmacologic evaluation of gentamicin in newborn infants.

Authors:  G H McCracken; D F Chrane; M L Thomas
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

7.  Comparative clinical studies of ototoxicity and nephrotoxicity of amikacin and gentamicin.

Authors:  S A Lerner; R Seligsohn; G J Matz
Journal:  Am J Med       Date:  1977-06       Impact factor: 4.965

8.  Pharmacokinetics of gentamicin in children and adults.

Authors:  G R Siber; P Echeverria; A L Smith; J W Paisley; D H Smith
Journal:  J Infect Dis       Date:  1975-12       Impact factor: 5.226

9.  Ototoxicity in neonates treated with gentamicin and kanamycin: results of a four-year controlled follow-up study.

Authors:  T Finitzo-Hieber; G H McCracken; R J Roeser; D A Allen; D F Chrane; J Morrow
Journal:  Pediatrics       Date:  1979-03       Impact factor: 7.124

10.  Elimination of tritiated gentamicin in normal human subjects and in patients with severely impaired renal function.

Authors:  T W Wilson; W A Mahon; T Inaba; G E Johnson; D Kadar
Journal:  Clin Pharmacol Ther       Date:  1973 Sep-Oct       Impact factor: 6.875

View more
  2 in total

Review 1.  Pharmacokinetics and pharmacodynamics of antibacterials, antifungals, and antivirals used most frequently in neonates and infants.

Authors:  Jessica K Roberts; Chris Stockmann; Jonathan E Constance; Justin Stiers; Michael G Spigarelli; Robert M Ward; Catherine M T Sherwin
Journal:  Clin Pharmacokinet       Date:  2014-07       Impact factor: 6.447

Review 2.  Extended-interval dosing of gentamicin for treatment of neonatal sepsis in developed and developing countries.

Authors:  Gary L Darmstadt; Mary Miller-Bell; Maneesh Batra; Paul Law; Kiely Law
Journal:  J Health Popul Nutr       Date:  2008-06       Impact factor: 2.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.